Related Experiment Video

Updated: Aug 15, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

[Cyclooxygenase 2 inhibitors and cancer chemoprevention]

Amine Masmoudi1, Thierry Le Chevalier, Laure Sabatier

  • 1Département de médecine, Institut Gustave-Roussy, 39 rue Camille-Desmoulins, 94805 Villejuif.

Bulletin Du Cancer
|July 9, 2004
PubMed

Insights

Chemoprevention uses compounds to prevent cancer. Targeting cyclooxygenase-2 (Cox2) is a promising strategy, as Cox2 overexpression drives cancer development through multiple mechanisms.

Area of Science:

  • Biochemistry
  • Oncology
  • Pharmacology

Context:

  • Carcinogenesis involves multiple molecular pathways.
  • Cyclooxygenase-2 (Cox2) is frequently overexpressed in various cancers.
  • Cox2 plays a significant role in promoting tumor development and progression.

Purpose:

  • To review the rationale behind targeting Cox2 for cancer prevention.
  • To explore current research on chemopreventive strategies focused on Cox2.
  • To highlight the potential of Cox2 inhibitors in chemoprevention.

Summary:

  • Chemoprevention aims to prevent cancer using natural or synthetic compounds.
  • Cyclooxygenase-2 (Cox2) is a key target due to its role in carcinogenesis.
  • Cox2 contributes to cancer via mechanisms like inflammation, angiogenesis, and apoptosis resistance.

Impact:

  • Identifies Cox2 as a crucial target for developing novel chemopreventive agents.
  • Provides insights into ongoing research for anticancer therapies.
  • Suggests potential for Cox2-targeted compounds in suppressing or reversing carcinogenic processes.

More Related Videos

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay05:17

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

Structure-Guided Design and Development of Novel Cyclophilin A Inhibitors and Ganoderiol-F Derivatives: An In-Silico Approach10:01

Structure-Guided Design and Development of Novel Cyclophilin A Inhibitors and Ganoderiol-F Derivatives: An In-Silico Approach

Published on: June 23, 2026

Related Concept Videos

Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...